Astellas Pharma (ALPMY) Earnings Date & Reports

Astellas Pharma Inc is a specialty global pharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALPMY is expected to report earnings to fall 42.34% to 16 cents per share on July 30

Astellas Pharma ALPMY Stock Earnings Reports

Q2'25

Est.

$0.17

Q1'25

Beat

by $0.16

Q4'24

Missed

by $0.41

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.08

The last earnings report on April 25 showed earnings per share of 29 cents, beating the estimate of 13 cents. With 154.52K shares outstanding, the current market capitalization sits at 26.55B.

View a ticker or compare two or three

Compare

ALPMY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALPMY
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsMajor

Profile

Fundamentals

Details

Industry

N/A

Address

2-5-1, Nihonbashi-Honcho

Phone

+81 332443000

Employees

16243

Web

http://www.astellas.com